|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.258 SEK | -7.77% |
|
-12.76% | -40.38% |
ExpreS2ion Biotech Holding AB (publ) reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was SEK 12.23 million compared to SEK 5.26 million a year ago. Revenue was SEK 13.73 million compared to SEK 15.26 million a year ago.
Net loss was SEK 43.93 million compared to SEK 31.71 million a year ago. Basic loss per share from continuing operations was SEK 1.5 compared to SEK 1.83 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -40.38% | 6.56M | |
| -3.15% | 89.69B | |
| +3.95% | 41.34B | |
| -10.51% | 33.72B | |
| +58.75% | 26.11B | |
| -20.09% | 14.63B | |
| -8.92% | 12.84B | |
| -11.46% | 11.66B | |
| -43.05% | 11.52B | |
| +4.64% | 8.92B |
EXPRES2ION BIOTECH HOLDING AB 